Introducing new screens: Why are we all doing different things?

Journal of Inherited Metabolic Disease

Volumn 30, Issue 4, 2007, Pages 423-429

  Pollitt, Rodney J ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN;

CLINICAL PRACTICE; CONFERENCE PAPER; CONGENITAL HYPOTHYROIDISM; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CYSTIC FIBROSIS; DISEASE MARKER; HEALTH CARE QUALITY; HEALTH PROGRAM; HOMOCYSTINURIA; HUMAN; INBORN ERROR OF METABOLISM; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; NEWBORN; NEWBORN SCREENING; PHENYLKETONURIA; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

GENETIC PREDISPOSITION TO DISEASE; GENETIC TECHNIQUES; HEALTH POLICY; HUMANS; INFANT, NEWBORN; MASS SPECTROMETRY; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 34548493905     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0647-2     Document Type: Conference Paper

References (27)

1. Alexander D, van Dycke PC (2006) A vision of the future of newborn screening. Pediatrics 117: S350-S354.
2. American College of Medical Genetics (2006) Newborn screening: Towards a uniform screening panel and system. Genet Med 8 (Supplement 1): 1S-252S.
3. Bolhuis PA, Page-Christiaens GCML (2005) Het advies 'Neonatale screening' van de Gezondheidsraad. Ned Tijdschr Geneeskd 149: 2857-2860.
4. Botkin JR, Clayton EW, Fost NC, et al (2006) Newborn screening technology: Proceed with caution. Pediatrics 117: 1793-1799.
5. Browning MF, Larson C, Strauss A, Marsden DL (2005) Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects. J Inherit Metab Dis 28: 545-550.
6. Dionisi-Vici C, Deodato F, Röschinger W, Rhead W, Wilcken B (2006) 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29: 383-389.
7. Fingerhut R, Roschinger W, Muntau AC, et al (2001) Hepatic carnitine palmitoyltransferase I deficiency: Acylcarnitine profiles in blood spots are highly specific. Clin Chem 47: 1763-1768.
8. Fletcher JM (2006) Screening for lysosomal storage disorders - a clinical perspective. J Inherit Metab Dis 29: 405-408.
9. Gelb MH, Turecek F, Scott CR, Chamoles NA (2006) Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 29: 397-404.
10. Giusti R, Badgwell A, Iglesias AD and the New York Cystic Fibrosis Screening Consortium (2007) New York State Cystic Fibrosis Consortium: The first 2.5 years experience with cystic fibrosis newborn screening in an ethnically diverse population. Pediatrics 119: E460-e467.
11. International Atomic Energy Agency (2005) Screening of newborns for congenital hypothyroidism: Guidance for developing programmes. Vienna, International Atomic Energy Agency. [Available at: http://www.iaea.org/ books].
12. Kwon C, Farrell PM (2000) The magnitude and challenge of false-positive newborn screening test results. Arch Pediatr Adolesc Med 154: 714-718.
13. Lanting CI, van Tijn DA, Loeber JG, Vulsma T, de Vijlder JJM, Verkerk PH (2005) Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program. Pediatrics 116: 168-173.
14. 14:1-carnitine levels. Pediatrics 118: 1065-1069.
15. Loeber JG (2007) Neonatal screening in Europe in 2004. J Inherit Metab Dis 30. doi: 10.1007/s10545-007-0644-5.
16. Lund AM (2005) Neonatal metabolic screening in Denmark. 101. Jahrestagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin, Bremen. Abstract K058.02V. [Avaialble at http://www.mh-hannover.de/tagungen/abs/dgkj2005/web/abstract/0190.htm accessed 15/03/2007].
17. National Screening Committee (2003) Second Report of the UK National Screening Committee. (http://www.nsc.nhs.uk); Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. March 2003. [Available at: http://rms.nelh.nhs.uk/common/ download.asp?resourceID=59772; accessed 21/3/2007].
18. Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S (2004) Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review. Health Technol Assess 8(12): 1-121.
19. Parsons EP, Clarke AJ, Hood K, Lycett E, Bradley DM (2002) Newborn screening for Duchenne muscular dystrophy: A psychosocial study. Arch Dis Child Fetal Neonatal Ed 86: F91-F95.
20. Pollitt RJ (1999) Principles and performance: Assessing the evidence. Acta Paediatr Scand 88(Supplement 432): 110-114.
21. Pollitt RJ (2006) International perspectives on newborn screening. J Inherit Metab Dis; 29: 390-396.
22. Stadler SC, Polanetz R, Maier EM, et al (2006) Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: Population heterogeneity of MCCA and MCCB mutations and the impact on risk assessment. Hum Mutat 27: 748-759.
23. Tarini BA, Christakis DA, Welch HG (2006) State newborn screening in the tandem mass spectrometry era: More tests, more false positive results. Pediatrics 118: 448-456. [Comment: Pediatrics (2007 Feb); 119: 414-415; author reply 415].
24. van Maldegem BT, Duran M, Wanders RJ et al (2006) Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. JAMA 23: 943-952.
25. Waisbren SE (2006) Newborn screening for metabolic disorders. JAMA 23: 993-995.
26. Walter JH, Wraith JE, White FJ, Bridge C, Till J (1998) Strategies for the treatment of cystathionine α-synthase deficiency: The experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr 157(Supplement 2): S71-S76.
27. Wilson JMG, Junger G (1968) Principles and practice of screening for disease. Public health papers no. 34. Geneva: World Health Organization.